385 related articles for article (PubMed ID: 24824298)
1. Cocrystal dissociation in the presence of water: a general approach for identifying stable cocrystal forms.
Eddleston MD; Madusanka N; Jones W
J Pharm Sci; 2014 Sep; 103(9):2865-2870. PubMed ID: 24824298
[TBL] [Abstract][Full Text] [Related]
2. An investigation of the causes of cocrystal dissociation at high humidity.
Eddleston MD; Thakuria R; Aldous BJ; Jones W
J Pharm Sci; 2014 Sep; 103(9):2859-2864. PubMed ID: 24481664
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic Insight into Caffeine-Oxalic Cocrystal Dissociation in Formulations: Role of Excipients.
Duggirala NK; Vyas A; Krzyzaniak JF; Arora KK; Suryanarayanan R
Mol Pharm; 2017 Nov; 14(11):3879-3887. PubMed ID: 28990387
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms by which moisture generates cocrystals.
Jayasankar A; Good DJ; Rodríguez-Hornedo N
Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034
[TBL] [Abstract][Full Text] [Related]
5. Screening for pharmaceutical cocrystal hydrates via neat and liquid-assisted grinding.
Karki S; Friscić T; Jones W; Motherwell WD
Mol Pharm; 2007; 4(3):347-54. PubMed ID: 17497885
[TBL] [Abstract][Full Text] [Related]
6. Role of Lattice Disorder in Water-Mediated Dissociation of Pharmaceutical Cocrystal Systems.
Kaur N; Duggirala NK; Thakral S; Suryanarayanan R
Mol Pharm; 2019 Jul; 16(7):3167-3177. PubMed ID: 31117742
[TBL] [Abstract][Full Text] [Related]
7. Physical stability enhancement of theophylline via cocrystallization.
Trask AV; Motherwell WD; Jones W
Int J Pharm; 2006 Aug; 320(1-2):114-23. PubMed ID: 16769188
[TBL] [Abstract][Full Text] [Related]
8. High-throughput 96-well solvent mediated sonic blending synthesis and on-plate solid/solution stability characterization of pharmaceutical cocrystals.
Luu V; Jona J; Stanton MK; Peterson ML; Morrison HG; Nagapudi K; Tan H
Int J Pharm; 2013 Jan; 441(1-2):356-64. PubMed ID: 23178596
[TBL] [Abstract][Full Text] [Related]
9. Following the surface response of caffeine cocrystals to controlled humidity storage by atomic force microscopy.
Cassidy AM; Gardner CE; Jones W
Int J Pharm; 2009 Sep; 379(1):59-66. PubMed ID: 19539735
[TBL] [Abstract][Full Text] [Related]
10. Effect of cocrystallization techniques on compressional properties of caffeine/oxalic acid 2:1 cocrystal.
Aher S; Dhumal R; Mahadik K; Ketolainen J; Paradkar A
Pharm Dev Technol; 2013 Feb; 18(1):55-60. PubMed ID: 21981663
[TBL] [Abstract][Full Text] [Related]
11. Dry Mechanochemical Synthesis of Caffeine/Oxalic Acid Cocrystals and Their Evaluation by Powder X-Ray Diffraction and Chemometrics.
Otsuka Y; Ito A; Takeuchi M; Tanaka H
J Pharm Sci; 2017 Dec; 106(12):3458-3464. PubMed ID: 28797789
[TBL] [Abstract][Full Text] [Related]
12. Novel furosemide cocrystals and selection of high solubility drug forms.
Goud NR; Gangavaram S; Suresh K; Pal S; Manjunatha SG; Nambiar S; Nangia A
J Pharm Sci; 2012 Feb; 101(2):664-80. PubMed ID: 22081478
[TBL] [Abstract][Full Text] [Related]
13. Application of spray freeze drying to theophylline-oxalic acid cocrystal engineering for inhaled dry powder technology.
Tanaka R; Hattori Y; Otsuka M; Ashizawa K
Drug Dev Ind Pharm; 2020 Feb; 46(2):179-187. PubMed ID: 31937148
[TBL] [Abstract][Full Text] [Related]
14. Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid.
Li Z; Matzger AJ
Mol Pharm; 2016 Mar; 13(3):990-5. PubMed ID: 26837376
[TBL] [Abstract][Full Text] [Related]
15. Theophylline-nicotinamide cocrystal formation in physical mixture during storage.
Ervasti T; Aaltonen J; Ketolainen J
Int J Pharm; 2015; 486(1-2):121-30. PubMed ID: 25800677
[TBL] [Abstract][Full Text] [Related]
16. Rapid conversion of API hydrates to anhydrous forms in aqueous media.
Petrova RI; Peresypkin A; Mortko CJ; McKeown AE; Lee J; Williams JM
J Pharm Sci; 2009 Nov; 98(11):4111-8. PubMed ID: 19384923
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the relative stability of pharmaceutical cocrystals consisting of paracetamol and dicarboxylic acids.
Suzuki N; Kawahata M; Yamaguchi K; Suzuki T; Tomono K; Fukami T
Drug Dev Ind Pharm; 2018 Apr; 44(4):582-589. PubMed ID: 29132223
[TBL] [Abstract][Full Text] [Related]
18. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
[TBL] [Abstract][Full Text] [Related]
19. Instability in theophylline and carbamazepine hydrate tablets: cocrystal formation due to release of lattice water.
Arora KK; Thakral S; Suryanarayanan R
Pharm Res; 2013 Jul; 30(7):1779-89. PubMed ID: 23568521
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical solvates, hydrates and amorphous forms: A special emphasis on cocrystals.
Healy AM; Worku ZA; Kumar D; Madi AM
Adv Drug Deliv Rev; 2017 Aug; 117():25-46. PubMed ID: 28342786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
